Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours Β· Estimated delivery Aug 8 - Aug 13
Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota
I could not ignore the benefits of IV Therapy and am excited about Hang 10 Drips
GaoZYinJZhangJWardREMartinRJLefevreMet al
Die produktespezifischen Angaben in der Fach- und Patienteninformation mssen beachtet werden
Table of Contents 1 Preface 2 Executive Summary 3 Overview of GLP-1 Agonists 4 Patient Profile: GLP-1 Agonists 5 GLP-1 Agonists: Epidemiology Snapshot 6 GLP-1 Agonists: Market Dynamics 7 GLP-1 Agonists: Key Facts Covered 8 GLP-1 Agonists, Drug Pipeline Assessment 9 Drug Pipeline Comparative Analysis 10 GLP-1 Agonists Drug Pipeline - Late-Stage Products (Phase III and IV) (Top Drugs) 11 GLP-1 Agonists Drug Pipeline - Mid-Stage Products (Phase II) (Top Drugs) 12 GLP-1 Agonists Drug Pipeline - Early-Stage Products (Phase I) (Top Drugs) 13 GLP-1 Agonists Drug Pipeline - Preclinical and Discovery Stage Products (Top Drugs) 14 GLP-1 Agonists, Key Drug Pipeline Companies 15 Regulatory Framework for Drug Approval, By Region 16 Terminated or Suspended Pipeline Products
iScience 27 , 110911 (2024)
US$ 29.40
US$ 23.23
US$ 24.94
US$ 20.30
US$ 24.33
US$ 28.30
US$ 25.22
